Immunoprevention for High-risk Lung Lesions

Clinical trial NCT07284485 · RECRUITING

Trial details

NCT number: NCT07284485
Sponsor: Robert Samstein
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-risk Lung Nodules

Start date: 2026-05-21
Primary completion: 2027-12-15
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.